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The use of platform materials and processes for new products help streamline process development, 
enhance predictability and efficiency during manufacturing, and simplify the raw materials supply chain. 
Although common, adaptation of cell expression systems can require a significant amount of process 
development work to achieve desired product yield, quality, and comparability. Here, we present a 
progressive development approach for evaluating platform media and feeds for an acquired cell culture 
process.  
A CHO-DG 44 cell line expressing a novel antibody product was procured through acquisition. The 
original non-platform media and fed-batch process yielded titers of approximately 3 g/L.  A study was 
performed to evaluate the cell line performance in the platform media and feeds that are designed 
mainly for CHO-K1 based cell lines with the aim of determining whether the platform media and feed 
system would be suitable as-is, or with only minor alterations. The cell growth and titers with the 
platform media and feeds were found to be approximately 1g/L.  While the per-cell specific productivity 
(pg/cell-day) was found to be comparable to the non-platform process, cell growth was substantially less 
with the platform media.  As a next step, minor modifications were made to the platform basal media 
including modifications to the starting osmolality, and the use of amino acid supplements. The 
modifications resulted in an increase in the cell growth comparable to the non- platform conditions only 
during the early phase of production.  This was possibly due to high ammonia levels observed in most 
platform conditions after the first few days of production culture. While improved, the culture 
performance with small modifications to the platform system was not considered adequate.  Therefore, 
based on cell biology considerations, existing process knowledge, and literature review, two redesigned 
platform media were evaluated and further improvements were realized – i.e. an overall 40-50% 
increase in titer and cell growth compared to control platform conditions under shake flask conditions.  
Further work is ongoing to confirm this observation in bioreactors. This study clearly demonstrates the 
cell culture challenges that come with adapting new and different cell lines to platform media and feed 
systems, the benefits and limitations of small adjustments, and the occasional need for larger media 
redesign efforts.  
 
